Innovations and Challenges in Renal Cancer: Summary Statement From the Third Cambridge Conference

被引:13
|
作者
Atkins, Michael B. [1 ]
Bukowski, Ronald M. [2 ]
Escudier, Bernard J. [3 ]
Figlin, Robert A. [4 ]
Hudes, Gary H. [5 ]
Kaelin, William G., Jr. [6 ]
Linehan, W. Marston [7 ]
McDermott, David F. [1 ]
Mier, James W. [1 ]
Pedrosa, Ivan [1 ]
Rini, Brian I. [2 ]
Signoretti, Sabina [8 ]
Sosman, Jeffrey A. [9 ]
Teh, Bin Tean [10 ]
Wood, Christopher G. [11 ]
Zurita, Amado J. [11 ]
King, Laura [12 ]
机构
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Cleveland Clin Fdn, Taussig Canc Inst, Cleveland, OH 44195 USA
[3] Inst Gustave Roussy, Unite Immunotherapie, Villejuif, France
[4] City Hope Comprehens Canc Ctr, Duarte, CA USA
[5] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[6] Howard Hughes Med Inst, Boston, MA 02115 USA
[7] NCI, Bethesda, MD 20892 USA
[8] Brigham & Womens Hosp, Boston, MA 02115 USA
[9] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
[10] Van Andel Res Inst, Grand Rapids, MI USA
[11] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[12] InforMED Commun Inc, Carlisle, MA USA
关键词
renal cancer; genetics; vascular endothelial growth factor; immunotherapy; biomarkers; IDENTIFICATION; INTERLEUKIN-2;
D O I
10.1002/cncr.24229
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Third Cambridge Conference on Innovations and Challenges in Renal Cancer, a symposium held in Cambridge, Massachusetts, June 27-28, 2008, and chaired by Michael B. Atkins, was convened to discuss the current state of knowledge in the field, critique new data, stimulate communication among those involved in basic and clinical research, and offer recommendations for further study. Four main topics were discussed: genetics and molecular biology of renal cell cancer, staging and prognosis, systemic therapy, and correlative science and biomarkers in stage IV disease. The conference format combined brief presentations with extended periods of discussion. The conclusions and recommendations are summarized in this paper and presented in more detail in the individual papers that follow. Cancer 2009;115(10 suppl):2247-51. (C) 2009 American Cancer Society.
引用
收藏
页码:2247 / 2251
页数:5
相关论文
共 50 条
  • [1] Innovations and challenges in renal cell carcinoma: Summary statement from the second Cambridge conference
    Atkins, Michael B.
    Ernstoff, Marc S.
    Figlin, Robert A.
    T Flaherty, Keith
    George, Daniel J.
    Kaelin, William G., Jr.
    Kwon, Eugene D.
    Libermann, Towia A.
    Linehan, W. Marston
    McDermott, David F.
    Ochoa, Augusto C.
    Pantuck, Allan J.
    Rini, Brian I.
    Rosen, Mark A.
    Sosman, Jeffrey A.
    Sukhatme, Vikas P.
    Vieweg, Johannes W.
    Wood, Christopher G.
    King, Laura
    [J]. CLINICAL CANCER RESEARCH, 2007, 13 (02) : 667S - 670S
  • [2] Innovations and challenges in melanoma: Summary statement from the first Cambridge conference
    Atkins, MB
    Elder, DE
    Essner, R
    Flaherty, KT
    Gajewski, TF
    Haluska, FG
    Hwu, P
    Keilholz, U
    Kirkwood, JM
    Mier, JW
    Ross, MI
    Slingluff, CL
    Sondak, VK
    Sosman, JA
    Weinstock, MA
    King, L
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (07) : 2291S - 2296S
  • [3] Innovations and challenges in prostate cancer: Summary statement for the 6th Cambridge conference
    Kantoff, Philip W.
    Beer, Tomasz M.
    D'Amico, Anthony V.
    DiPaola, Robert S.
    Eisenberger, Mario. A.
    Hussain, Maha H. A.
    Kelly, William Kevin
    Mathew, Paul
    Morris, Michael J.
    Ryan, Charles J.
    Sandler, Howard M.
    Thompson, Ian M.
    Carroll, Peter R.
    [J]. JOURNAL OF UROLOGY, 2007, 178 (03): : S5 - S8
  • [4] Innovations and challenges in renal cancer: Consensus statement from the first international conference
    Atkins, MB
    Avigan, DE
    Bukowski, RM
    Childs, RW
    Dutcher, JP
    Eisen, TG
    Figlin, RA
    Finke, JH
    Flanigan, RC
    George, DJ
    Goldberg, SN
    Gordon, MS
    Iliopoulos, O
    Kaelin, WG
    Linehan, WM
    Lipton, A
    Motzer, RJ
    Novick, AC
    Stadler, WM
    Teh, BT
    Yang, JC
    King, L
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (18) : 6277S - 6281S
  • [5] Advances in treating metastatic bone cancer: Summary statement for the First Cambridge Conference
    Lipton, Allan
    Berenson, James R.
    Body, Jean-Jacques
    Boyce, Brendan F.
    Bruland, Oyvind S.
    Carducci, Michael A.
    Cleeland, Charles S.
    Clohisy, Denis R.
    Coleman, Robert E.
    Cook, Richard J.
    Guise, Theresa A.
    Pearse, Roger N.
    Powles, Trevor J.
    Rogers, Michael J.
    Roodman, G. David
    Smith, Matthew R.
    Suva, Larry J.
    Vessella, Robert L.
    Weilbaecher, Katherine N.
    King, Laura
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (20) : 6209S - 6212S
  • [6] Endocrine and Targeted Manipulation of Breast Cancer: Summary statement for the Sixth Cambridge Conference
    Come, Steven E.
    Buzdar, Aman U.
    Ingle, James N.
    Johnston, Stephen R. D.
    Brodie, Angela M.
    Coombes, R. Charles
    Miller, William R.
    Pritchard, Kathleen I.
    Winer, Eric P.
    Zujewski, Jo Anne
    Goss, Paul E.
    [J]. CANCER, 2008, 112 (03) : 673 - 678
  • [7] Third International Conference on Innovations and Challenges in Prostate Cancer: Prevention, detection and treatment
    Carroll, PR
    Benaron, DA
    Blackledge, G
    Coakley, FV
    D'Amico, AV
    Higano, CS
    Iversen, P
    Kattan, M
    Nanus, DM
    Nelson, JB
    Oh, WK
    Roach, M
    Sellers, WR
    Smith, MR
    McMann, MC
    Kantoff, PW
    [J]. JOURNAL OF UROLOGY, 2003, 170 (06): : S3 - S5
  • [8] Proceedings of the Third International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: Conference summary statement
    Come, SE
    Buzdar, AU
    Arteaga, CL
    Bissell, MJ
    Brown, MA
    Ellis, MJ
    Goss, PE
    Green, JE
    Ingle, JN
    Lee, AV
    Medina, D
    Nicholson, RI
    Santen, RJ
    Schiff, R
    Hart, CS
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (01) : 327S - 330S
  • [9] Summary statement - Novel Agents in the Treatment of Lung Cancer: Fifth Cambridge Conference assessing opportunities for combination therapy
    Lynch, Thomas J., Jr.
    Blumenschein, George R., Jr.
    Engelman, Jeffrey A.
    Espinoza-Delgado, Igor
    Govindan, Ramaswamy
    Hanke, Jeff
    Hanna, Nasser H.
    Heymach, John V.
    Hirsch, Fred R.
    Janne, Pasi A.
    Lilenbaum, Rogerio C.
    Natale, Ronald B.
    Riely, Gregory J.
    Sequist, Lecia V.
    Shapiro, Geoffrey T.
    Shaw, Alice
    Shepherd, Frances A.
    Socinski, Mark
    Sorensen, A. Gregory
    Wakelee, Heather A.
    Weitzman, Aaron
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (06) : S107 - S112
  • [10] Novel agents in the treatment of lung cancer: Conference summary statement
    Lynch, TJ
    Adjei, AA
    Bunn, PA
    DuBois, RN
    Gandara, DR
    Giaccone, G
    Govindan, R
    Herbst, RS
    Johnson, BE
    Khuri, FR
    Perez-Soler, R
    Rosell, R
    Rowinsky, EK
    Sandler, AB
    Scagliotti, GV
    Schiller, JH
    Shapiro, GI
    Socinski, MA
    Hart, CS
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (12) : 4199S - 4204S